High-risk percutaneous coronary intervention
Showing 1 - 25 of >10,000
High-risk Percutaneous Coronary Intervention, Heart Disease, Coronary Trial (VITALYST System)
Not yet recruiting
- High-risk Percutaneous Coronary Intervention
- Heart Disease, Coronary
- VITALYST System
- (no location specified)
Nov 9, 2023
High-Risk Percutaneous Coronary Intervention Trial (Impella ECP)
Recruiting
- High-Risk Percutaneous Coronary Intervention
- Impella ECP
-
Detroit, MichiganAscension St. John Hospital
Dec 23, 2022
High-Risk Percutaneous Coronary Intervention Trial in Tbilisi (The Elevate™ System)
Active, not recruiting
- High-Risk Percutaneous Coronary Intervention
- The Elevate™ System
-
Tbilisi, GeorgiaIsraeli-Georgian Medical Research Clinic "Helsicore"
Oct 24, 2023
High-risk Percutaneous Coronary Intervention Trial in New York (The Elevate™ System)
Not yet recruiting
- High-risk Percutaneous Coronary Intervention
- The Elevate™ System
-
New York, New YorkNew York-Presbyterian Hospital/Columbia University Irving Medica
Feb 3, 2023
Pressure-Volume Loop During High-Risk PCI
Recruiting
- Coronary Artery Disease
- High-risk percutaneous coronary intervention
-
Detroit, MichiganHenry Ford Hospital
Dec 6, 2022
High-risk Percutaneous Coronary Intervention Trial in Boston, Detroit, Cincinnati (Impella ECP)
Recruiting
- High-risk Percutaneous Coronary Intervention
- Impella ECP
-
Boston, Massachusetts
- +3 more
Jun 27, 2022
Ventricular Assist Device Trial (Supira System)
Not yet recruiting
- Ventricular Assist Device
- Supira System
- (no location specified)
Oct 11, 2023
Coronary Microvascular Dysfunction Trial in Beijing (Bivalirudin, standard heparin)
Active, not recruiting
- Coronary Microvascular Dysfunction
- Bivalirudin
- standard heparin
-
Beijing, Beijing, ChinaPeking university first hospital
Aug 1, 2023
Coronary Artery Disease Trial (Routine Angiography Follow-up, Routine Clinical Follow-up)
Not yet recruiting
- Coronary Artery Disease
- Routine Angiography Follow-up
- Routine Clinical Follow-up
- (no location specified)
Jun 20, 2023
Associated With In-stent Restenosis After Percutaneous Coronary
Not yet recruiting
- In-stent Restenosis
- bone morphogenetic protein-2 (BMP-2)
- (no location specified)
Nov 20, 2023
IHD, LV Dysfunction Trial in Copenhagen (PCI, CABG)
Not yet recruiting
- IHD
- LV Dysfunction
- PCI
- CABG
-
Copenhagen, DenmarkRigshospitalet, University of Copenhagen
Sep 11, 2022
Ischemic Heart Disease, Coronary Artery Disease Trial in London (Percutaneous left ventricular unloading)
Recruiting
- Ischemic Heart Disease
- Coronary Artery Disease
- Percutaneous left ventricular unloading
-
London, United KingdomGuy's and St Thomas' NHS Foundation Trust
Aug 3, 2022
Coronary Artery Disease Trial in Seoul (Percutaneous coronary intervention)
Recruiting
- Coronary Artery Disease
- Percutaneous coronary intervention
-
Seoul, Korea, Republic ofSamsung Medical Center
Sep 6, 2022
High Bleeding Risk, Coronary Artery Disease, Percutaneous Coronary Intervention Trial in Ciudad de México (Zotarolimus eluting
Recruiting
- High Bleeding Risk
- +2 more
- Zotarolimus eluting stent
- Sirolimus eluting stent
-
Ciudad de México, MexicoInstituto Nacional de Cardiología "Ignacio Chávez"
Feb 17, 2022
Coronary Artery Disease Trial in Seoul (Aspirin, Clopidogrel)
Recruiting
- Coronary Artery Disease
-
Seoul, Korea, Republic ofSamsung Medical Center
Feb 8, 2022
Coronary Stenosis Trial in Tel Aviv (Percutaneous Coronary Intervention (PCI))
Completed
- Coronary Stenosis
- Percutaneous Coronary Intervention (PCI)
-
Tel Aviv, IsraelMedinol LTD
Aug 31, 2021
Bleeding and Ischemic Risk
Completed
- Coronary Artery Disease
- Percutaneous Coronary Intervention
- Percutaneous coronary intervention
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Oct 13, 2023
Myocardial Infarction Trial in Denmark (CYP2C19*2/*3, Shorter DAPT duration)
Not yet recruiting
- Myocardial Infarction
- CYP2C19*2/*3
- Shorter DAPT duration
-
Aalborg, Denmark
- +5 more
Mar 3, 2022
Acute Myocardial Infarction, Heart Failure Trial in Seoul (SGLT2 inhibitor, Control)
Recruiting
- Acute Myocardial Infarction
- Heart Failure
- SGLT2 inhibitor
- Control
-
Seoul, Korea, Republic ofSamsung Medical Center
Aug 11, 2021
Coronary Artery Disease With Myocardial Infarction Trial in Korea, Republic of (routine stress testing, No Routine stress
Completed
- Coronary Artery Disease With Myocardial Infarction
- routine stress testing
- No Routine stress testing
-
Chuncheon, Korea, Republic of
- +10 more
Apr 3, 2022
High Bleeding Risk, Coronary Artery Disease (CAD), Percutaneous Coronary Intervention (PCI) Trial in Ciudad de México (Drug
Terminated
- High Bleeding Risk
- +2 more
- Drug Eluting Balloon (DEB)
- Drug Eluting Stents (DES)
-
Ciudad de México, MexicoInstituto Nacional de Cardiologia "Ignacio Chávez"
Oct 19, 2021
Coronary Artery Disease, Percutaneous Coronary Intervention, Acute Coronary Syndrome Trial in Seoul (PPI, P-CAB 25, P-CAB 50)
Recruiting
- Coronary Artery Disease
- +3 more
- PPI
- +2 more
-
Seoul, Korea, Republic ofAsan Medical Center
Mar 6, 2022
Chronic Total Occlusion of Coronary Artery, Angina Pectoris, Quality of Life Trial in Bergen, Glasgow (Chronic total
Recruiting
- Chronic Total Occlusion of Coronary Artery
- +3 more
- Chronic total occlusion(CTO) percutaneous coronary intervention (PCI)
-
Bergen, Norway
- +1 more
Dec 8, 2021